| Super 1 Pharmacy #601 | |
| 604 Macarthur Dr, Alexandria, Louisiana 71303 | |
| (318) 442-5710 |
| Name | Super 1 Pharmacy #601 |
|---|---|
| Organization Name | Brookshire Grocery Company |
| Location | 604 Macarthur Dr, Alexandria, Louisiana 71303 |
| Type | Pharmacy |
| Phone | (318) 442-5710 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The 1st International Abu Dhabi Diabetes Congress kicked off today with over 500 of the leading diabetologists and healthcare professionals from around the world in attendance.
Researchers from IMIM (Hospital del Mar Medical Research Institute) have identified a new protein, galectin-1, as a possible therapeutic target for pancreatic cancer.
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Cabergoline Tablets USP, 0.5 mg. Cabergoline Tablets USP are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product.
A new study led by researchers in the UNC Department of Pediatrics finds a direct correlation between more severe forms of obesity in children and related risk factors for developing heart disease and diabetes—particularly in boys.
› Verified 4 days ago
| NPI Number | 1871666347 |
| Organization Name | BROOKSHIRE GROCERY COMPANY |
| Doing Business As | SUPER 1 PHARMACY |
| Type | Pharmacy |
| Address | 604 Macarthur Dr, Attention Pharmacy Dept, Alexandria, LA 71303 |
| Phone Number | 318-442-5710 |
News Archive
The 1st International Abu Dhabi Diabetes Congress kicked off today with over 500 of the leading diabetologists and healthcare professionals from around the world in attendance.
Researchers from IMIM (Hospital del Mar Medical Research Institute) have identified a new protein, galectin-1, as a possible therapeutic target for pancreatic cancer.
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Cabergoline Tablets USP, 0.5 mg. Cabergoline Tablets USP are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product.
A new study led by researchers in the UNC Department of Pediatrics finds a direct correlation between more severe forms of obesity in children and related risk factors for developing heart disease and diabetes—particularly in boys.
› Verified 4 days ago
| NPI Number | 1982382230 |
| Organization Name | WALGREEN CO. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 604 Macarthur Dr, Alexandria, LA 71303 |
| Phone Number | 318-442-5710 |
News Archive
The 1st International Abu Dhabi Diabetes Congress kicked off today with over 500 of the leading diabetologists and healthcare professionals from around the world in attendance.
Researchers from IMIM (Hospital del Mar Medical Research Institute) have identified a new protein, galectin-1, as a possible therapeutic target for pancreatic cancer.
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Cabergoline Tablets USP, 0.5 mg. Cabergoline Tablets USP are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product.
A new study led by researchers in the UNC Department of Pediatrics finds a direct correlation between more severe forms of obesity in children and related risk factors for developing heart disease and diabetes—particularly in boys.
› Verified 4 days ago
News Archive
The 1st International Abu Dhabi Diabetes Congress kicked off today with over 500 of the leading diabetologists and healthcare professionals from around the world in attendance.
Researchers from IMIM (Hospital del Mar Medical Research Institute) have identified a new protein, galectin-1, as a possible therapeutic target for pancreatic cancer.
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Cabergoline Tablets USP, 0.5 mg. Cabergoline Tablets USP are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product.
A new study led by researchers in the UNC Department of Pediatrics finds a direct correlation between more severe forms of obesity in children and related risk factors for developing heart disease and diabetes—particularly in boys.
› Verified 4 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 21a Heyman Ln, Alexandria, Louisiana 71303 Phone: (318) 442-1133 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1630 N Macarthur Dr, Alexandria, Louisiana 71303 Phone: (318) 442-6467 | |
Cvs Pharmacy #05607 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4443 Jackson Street Ext, Alexandria, Louisiana 71303 Phone: (318) 448-1683 | |
Cvs Pharmacy #05276 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 721 Bolton Ave, Alexandria, Louisiana 71301 Phone: (318) 443-8405 | |
Kroger Pharmacy #381 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1422 Macarthur Dr, Alexandria, Louisiana 71301 Phone: (318) 442-0514 |